Penn, Roche’s Genentech Near Settlement on Cancer-Drug Patents

March 10, 2025, 9:34 PM UTC

A federal judge in Delaware paused the University of Pennsylvania’s lawsuit against Roche Holding AG’s Genentech accusing four cancer treatments of infringing a since-expired patent while the parties work to finalize a deal that would end the dispute.

Judge Jennifer L. Hall granted a request by Penn and Genentech Inc. “to stay this action pending performance of certain obligations under the settlement agreement reached by the parties,” according to an order issued Monday in the US District Court for the District of Delaware.

The parties must file a stipulation of dismissal or a joint status report by March 24, it ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.